These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 36879561)

  • 1. The next psychoactive drugs: From imipramine to ketamine.
    Carrillo P; Petit AC; Gaillard R; Vinckier F
    Bull Acad Natl Med; 2020 Dec; 204(9):e169-e177. PubMed ID: 36879561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The next psychoactive drugs: From imipramine to ketamine].
    Carrillo P; Petit AC; Gaillard R; Vinckier F
    Bull Acad Natl Med; 2020 Dec; 204(9):1034-1042. PubMed ID: 32963409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A brief history of antidepressant drug development: from tricyclics to beyond ketamine.
    Pereira VS; Hiroaki-Sato VA
    Acta Neuropsychiatr; 2018 Dec; 30(6):307-322. PubMed ID: 29388517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
    Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
    J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A historical review of antidepressant effects of ketamine and its enantiomers.
    Wei Y; Chang L; Hashimoto K
    Pharmacol Biochem Behav; 2020 Mar; 190():172870. PubMed ID: 32035078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacology of ketamine and esketamine as rapid-acting antidepressants].
    Pavlidi P; Megalokonomou A; Sofron A; Kokras N; Dalla C
    Psychiatriki; 2021 Dec; 32(Supplement I):55-63. PubMed ID: 34990380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ketamine's antidepressant effect: focus on ketamine mechanisms of action].
    De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
    Encephale; 2014 Feb; 40(1):48-55. PubMed ID: 24434007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.
    Hashimoto K
    Psychiatry Clin Neurosci; 2019 Oct; 73(10):613-627. PubMed ID: 31215725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Mechanisms Underlying Antidepressant Responses of Ketamine and Imipramine.
    Wei Z; Zhang K; Zhou Q; Huang M; Xu T; Dong J; Zheng Y; Cai X
    CNS Neurol Disord Drug Targets; 2017; 16(7):846-853. PubMed ID: 28462695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ketamine's antidepressant effect: literature review on clinical use].
    De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
    Encephale; 2014 Feb; 40(1):15-23. PubMed ID: 24434008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine treatment for depression: a review.
    Yavi M; Lee H; Henter ID; Park LT; Zarate CA
    Discov Ment Health; 2022; 2(1):9. PubMed ID: 35509843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal esketamine: From origins to future implications in treatment-resistant depression.
    Sanders B; Brula AQ
    J Psychiatr Res; 2021 May; 137():29-35. PubMed ID: 33647726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of ketamine action as an antidepressant.
    Zanos P; Gould TD
    Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk Between Inflammation and Glutamate System in Depression: Signaling Pathway and Molecular Biomarkers for Ketamine's Antidepressant Effect.
    Cui W; Ning Y; Hong W; Wang J; Liu Z; Li MD
    Mol Neurobiol; 2019 May; 56(5):3484-3500. PubMed ID: 30140973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.
    du Jardin KG; Müller HK; Elfving B; Dale E; Wegener G; Sanchez C
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():27-38. PubMed ID: 27262695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine's antidepressant action: beyond NMDA receptor inhibition.
    Hashimoto K
    Expert Opin Ther Targets; 2016 Nov; 20(11):1389-1392. PubMed ID: 27646666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine's mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine's antidepressant effects?
    Quintanilla B; Zarate CA; Pillai A
    Mol Psychiatry; 2024 Sep; 29(9):2849-2858. PubMed ID: 38575806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esketamine and rapastinel, but not imipramine, have antidepressant-like effect in a treatment-resistant animal model of depression.
    Pereira VS; Joca SRL; Harvey BH; Elfving B; Wegener G
    Acta Neuropsychiatr; 2019 Oct; 31(5):258-265. PubMed ID: 31230597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multiscale View of the Mechanisms Underlying Ketamine's Antidepressant Effects: An Update on Neuronal Calcium Signaling.
    Kawatake-Kuno A; Murai T; Uchida S
    Front Behav Neurosci; 2021; 15():749180. PubMed ID: 34658809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.